Netherlands· NL-cd6fae131d85

Alipalmtin 10 mg zachte capsules

A alitretinoin product containing alitretinoïne, registered in Netherlands by Orifarm Healthcare A/S. The same ATC class is registered in 8 of our 19 countries.

ATC D11AH04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about alitretinoïneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Alitretinoin is registered in 8 of 19 countries.

Countries holding a registration under ATC D11AH04 (alitretinoin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search alitretinoin products by name

Alitretinoin · ATC D11AH04

8 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Netherlands
Norwayprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alitretinoin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Alitretinoin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$17.29

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ALITRETINOÏNE
Manufacturer: Orifarm Healthcare A/S
Country: Netherlands (NL)
ATC code: D11AH04
ATC class: Alitretinoin
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
121503

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for alitretinoin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check alitretinoin against other medicines How interaction checks work

Alitretinoin · interactions on record

5 records

1 severe
4 moderate

Most severe, free to view

Aminolevulinic acidL01XD04severe
Salicylic acidD01AE12moderate
Porfimer sodiumL01XD01moderate
MethoxsalenL01XD10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alitretinoin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alitretinoin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

Austria · Alitretan, Toctino
Belgium · Alitretinoin Orifarm
Germany · Alitrederm, Toctino
Denmark · Alitretinoin Orifarm, Toctino
Spain · Alitretinoína Ifc, Toctino
Finland · Alitretinoin Orifarm, Toctino
France · Alizem, Toctino
United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
Italy · Alitrecare, Toctino
Norway · Alitretinoin Orifarm, Toctino
Portugal · Alitretinoína Cantabria
Sweden · Alitretinoin Orifarm
Slovenia · Toctino

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/3f27134f-5919-41d0-8424-ae85a9e7e309
GET /v1/drugs/3f27134f-5919-41d0-8424-ae85a9e7e309?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h121503_smpc.pdf",
  "strength": null,
  "atc_label": "Alitretinoin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg121503",
  "excipients": [
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "GLYCEROLMONOSTEARAAT (E 471)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "PLANTAARDIGE OLIE, GEHYDREERD",
    "SOJABOONOLIE, GEDEELTELIJK GEHYDREERD  (E 479b)",
    "SOJAOLIE, GEZUIVERD",
    "SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
    "TITAANDIOXIDE (E 171)",
    "TOCOFEROL, DL-ALFA (E 307)",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "ALITRETINOÏNE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h121503.pdf",
  "authorised_at": "2019/01/18",
  "procedure_number": "NL/H/4060/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "121503",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about alitretinoin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console